Fabio Ivankovich Email & Phone Number

State Of São Paulo, Brazil

CEO of Genesis Genomics, a joint venture of Hospital Albert Einstein and Fleury

Thousand Oaks, CA, US

As a result of Amgen's acquisition of Horizon Therapeutics in October 2023, I am excited to share that I will continue my role leading Rare Disease BU in Brazil and supporting Rare Disease in LACAN Region

Dublin, Ireland, IE

• Leading Regional and Country GMs focused on international expansion in European Countries, Saudi Arabia and Japan (with a total team of over 80 people), with regulatory submission and launch of UPLIZNA, for NMSOD, and.
• Accumulating role of GM Brazil and Region LATAM and Canada. Launching UPLIZNA for NMOSD and TEPEZZA for TED (Thyroid Eye Disease) in Brazil (leading a team of 25 people) and preparing the launch of UPLIZNA in Canada

Dublin, Ireland, IE

• Definition of business model and strategy for other LATAM Countries: Argentina and Colombia
• Regulatory submission of 2 products (UPLIZNA and TEPEZZA) in Brazil (ANVISA) and Colombia (INVIMA). UPLIZNA was approved by ANVISA on December 26th, 2022 and TEPEZZA in June 2023
• Business Plan for Regulatory submission and launching of UPLIZNA and TEPEZZA in Canada

Dublin, Ireland, IE

• Led Horizon's startup in Brazil, Legal Entity, ANVISA`s License, establishing the office in Sao Paulo, working together with Headquarter in Deerfield – IL (USA)
• Responsible for the definition of structure, planning (medium and long terms), hiring employees, local vendors, building the company's image in Brazil with several stakeholders and other actions

Dublin, Ireland, IE

Led Horizon's startup in Brazil from scratch, starting with legal entity and Anvisa’s licenses, working together with Headquarter in IL (United States)

Cambridge, MA, US

• Led Sarepta's startup in Brazil from green field working together with Headquarter in Cambridge (United States).
• Responsible for the definition of structure, planning (medium and long terms), hiring employees and vendors, building the company's image in Brazil with several stakeholders and other actions.
• Spearheaded the construction of the company’s culture in Brazil engaging people. Sarepta was certified as a Great Place to Work (GPTW) in 2019 and 2020.
• Built strategies for public access, regulatory, marketing, commercial, patient associations and government agencies.
• Responsible for getting all licenses and registering medicines for rare diseases in the Brazilian market, including gene therapy preparation.
• Each Step Matters – innovative project focused on DMD Disease Awareness and inclusion (partnership with Mauricio de Sousa Produções) engaging Patient Associations – strong PR Strategy with a huge repercussion (more.

Tokyo, JP, JP

• Responsible for a structure with 26 people, including Product Manager, Marketing Assistant, Sales Managers and Sale Representatives.
• Neuroscience – ADHD:o Venvanse – repositioning of product strategy, focused on market leadership. In 2014, 3rd market share in Brazil. In 2016, reached leadership in value and units (YTD). In 2017, YTD market share.
• Gastrointestinal / Internal Medicine:o Launch plan for a product focused on Hypoparathyroidism and another one for Short Bowel Syndrome (both, rare diseases) – market research (BI) working together with Medical Affairs.
• Ophthalmic:o Launch plan for Xiidra in Brazil for dry eye disease mapping the market (BI), establishing a long-term plan, considering P&L and all marketing and commercial strategies (access public and private).

Switzerland 🇨🇭, CH

• Responsible for a structure with 130 people including Product Managers, Marketing Coordinators, Sales Managers and Representatives.
• Led a project focused on Public Market (access) - MabThera and Actemra for the treatment of Rheumatoid Arthritis and Pegasys for Hepatitis C (centralized purchase by the Ministry of Health).o Resulted in sales to the.
• Led the strategy for mature products such as Prolopa (Parkinsons), Pulmozyme (Fibrosis) and Valcyte (Transplants).o Maintenance of Prolopa sales growth in 2013 even with the launch of a generic competitor as well as.
• Reorganized internal and sales force structures.o More effectiveness with cost control.

Switzerland 🇨🇭, CH

• Responsible for a new Business Unit at Roche Brazil with 2 Product Managers, 2 Marketing Coordinators, 1 National Sales Manager, 4 Territory Managers, and 23 Sales Representatives.
• Established a strategy for two different biologic products (MabThera and Actemra) focused on the same disease (Rheumatoid Arthritis). Negotiation with Oncology and Rheumatology Infusion Centers.o Resulted in a clear.
• Led people management project focused on increasing employee engagement.o In a Global Survey (GEOS – Global Employee Opinion Survey), the BU reached 91% in 2011 in terms of engagement (Roche Brazil engagement was 72%).
• Member of the Management Team working on the new structure of Roche Brazil and new procedures focused on marketing, access, segmentation, and corporate engagement.o Resulted in a cultural change and increased the level.

Switzerland 🇨🇭, CH

• Acting in the price registration review process for Zelboraf (Oncology) - CMED

Switzerland 🇨🇭, CH

• Led the startup of RA Structure building an RA franchise in Brazil, with MabThera RA, pre-launching activities for Actemra, and hiring the Sales Force and Marketing team.o Annual sales growth of MabThera in Rheumatoid.

Switzerland 🇨🇭, CH

• Responsible for 8 Territorial Managers and more than 70 sales representatives, focused on Bonviva and Xenical.o Bonviva – 2nd position in 12 months (more than 30% market share – Brazilian Original Bisphosphonates.

Switzerland 🇨🇭, CH

• Set strategy and implemented Bonviva Brand Plan in Brazil. Pre-launch and launch in May 2006.o Resulted in one of the best Bonviva market shares in the world: over 30%.
• Central Nervous System - Managed Lexotan, Prolopa and Rivotril drawing up strategy to launch a new formulation for Lexotan (Lexotan drops) and Rivotril (sublingual), plus a protection strategy considering generic.
• Managed the post-launch of Tamiflu.
• Managed mature products including Bactrim, Rocaltrol, and Rocefin.

Switzerland 🇨🇭, CH

• Restructured an “in-house agency” and managed the Promotional Materials Warehouse with 15 subordinates.
• Led the process reducing by approximately 50% external promotion agency costs and increased quality control of printed materials, thereby reducing reprints costs.

Marketing Strategy and Sales Manager

BR

Sao Paulo, São Paulo, BR

Negotiation with suppliers; managing art designers

Clients like Nestle, Unilever, Seagram

Master Of Business Administration (M.B.A.), Executive Mba

Bachelor'S Degree, Social Communication -

Executive Mba - Marketing Champions Programme - 5 Days, 45 Hours

Ensino Médio Completo